Cargando…
Locoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without Radiation Therapy
Among breast cancer patients treated with neoadjuvant chemotherapy (NAC) and mastectomy, locoregional recurrence (LRR) rates are unclear in women with ER+ tumors treated with adjuvant endocrine therapy without postmastectomy radiation (PMRT). To determine if PMRT is needed in these patients, we comp...
Autores principales: | Kandula, Shravan, Switchenko, Jeffrey M., Harari, Saul, Fasola, Carolina, Mister, Donna, Yu, David S., Zelnak, Amelia B., Torres, Mylin A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523670/ https://www.ncbi.nlm.nih.gov/pubmed/26266050 http://dx.doi.org/10.1155/2015/147476 |
Ejemplares similares
-
Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast Cancer
por: Marcus, David M., et al.
Publicado: (2013) -
Locoregional and Distant Recurrence Patterns in Young versus Elderly Women Treated for Breast Cancer
por: Rudra, Soumon, et al.
Publicado: (2015) -
CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant Chemotherapy
por: Schlafstein, Ashley J., et al.
Publicado: (2018) -
Breast reconstruction and post-mastectomy radiation practice
por: Chen, Susie A, et al.
Publicado: (2013) -
Risk factors of locoregional relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy following mastectomy and radiotherapy
por: Huang, Liang, et al.
Publicado: (2016)